» Articles » PMID: 39910830

Vitamin C and Gallic Acid Ameliorate Motor Dysfunction, Cognitive Deficits, and Brain Oxidative Stress in a Valproic Acid-Induced Model of Autism

Overview
Journal Brain Behav
Date 2025 Feb 6
PMID 39910830
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Autism, a developmental-neurodegenerative disorder, often manifests as social communication difficulties and has been correlated to oxidative stress in the brain. Vitamins C and gallic acid (GA) possess potent antioxidant properties, making them potential candidates for addressing autism-related issues. This study examined the influence of vitamin C (Vit C) and GA on behavioral, motor, and cognitive performance, along with the assessment of brain oxidative markers, using an experimental model of autism.

Method: Fourteen female rats were divided into saline and valproic acid (VPA) groups, and mating with mature male rats generated offspring. VPA (500 mg/kg) was injected intraperitoneally (i.p.) on gestational day (GD) 12.5. Male pups remained undisturbed for 29 days. On postnatal day (PND) 30, 48 male pups were randomly selected and administered daily injections of Vit C (30 mg/kg, i.p.) or GA (30 mg/kg, i.p.) for 4 weeks (PND 38-65). Behavioral assessments were conducted before and after treatment (PND 30-37 and 66-73). Animals were then anesthetized, and their brains were analyzed for oxidative stress markers.

Finding: The prenatal VPA-induced autism model increased nociceptive threshold, heightened anxiety-like behaviors, impaired balance power, delayed spatial learning, elevated malondialdehyde, and decreased glutathione and catalase levels in the brains of the male offspring. Administration of Vit C and GA effectively mitigated these anomalies.

Conclusions: Vit C and GA could potentially alleviate anxiety-like behaviors, motor and cognitive deficits, and brain oxidative stress markers in a prenatal rat autism model. This underscores their viability as potential pharmacological interventions for treating autistic dysfunction.

References
1.
Abdullahi P, Raeis-Abdollahi E, Sameni H, Vafaei A, Ghanbari A, Rashidy-Pour A . Protective effects of morphine in a rat model of post-traumatic stress disorder: Role of hypothalamic-pituitary-adrenal axis and beta- adrenergic system. Behav Brain Res. 2020; 395:112867. DOI: 10.1016/j.bbr.2020.112867. View

2.
Al-Amin M, Rahman M, Khan F, Zaman F, Reza H . Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism. Behav Brain Res. 2015; 286:112-21. DOI: 10.1016/j.bbr.2015.02.041. View

3.
Saadat M, Taherian A, Aldaghi M, Raise-Abdullahi P, Sameni H, Vafaei A . Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid. Brain Behav. 2023; 13(11):e3224. PMC: 10636422. DOI: 10.1002/brb3.3224. View

4.
Pratico D . Alzheimer's disease and oxygen radicals: new insights. Biochem Pharmacol. 2002; 63(4):563-7. DOI: 10.1016/s0006-2952(01)00919-4. View

5.
Veselinovic A, Petrovic S, Zikic V, Subotic M, Jakovljevic V, Jeremic N . Neuroinflammation in Autism and Supplementation Based on Omega-3 Polyunsaturated Fatty Acids: A Narrative Review. Medicina (Kaunas). 2021; 57(9). PMC: 8464922. DOI: 10.3390/medicina57090893. View